Figure 1.
Overall design of re-purposed therapeutics. (A) Design of bexarotene prodrug and its chemical components; (B) layered arrangement of bexarotene-prodrug after self-assembling into a gas-filled bubble followed by its rupture upon US exposure; (C) prodrug interacts favorably with the cancer cell membrane to get inserted and eventually be cleaved enzymatically releasing the active pharmaceutical ingredient.